[Benefit assessment of bupropion, cytisine, nicotine and varenicline for tobacco cessation in severe tobacco dependence]

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018005559
German
Original Title: Nutzenbewertung von Bupropion, Cytisin, Nicotin und Vareniclin zur Tabakentwöhnung bei schwerer Tabakabhängigkeit
Details
Project Status: Completed
URL for project: https://www.iqwig.de/projekte/a22-34.html
Year Published: 2023
URL for published report: https://www.iqwig.de/download/a22-34_tabakentwoehnung-bei-schwerer-tabakabhaengigkeit_abschlussbericht_v1-0.pdf
English language abstract: There is no English language summary available
Publication Type: Full HTA
Country: Germany
DOI: https://doi.org/10.60584/A22-34
MeSH Terms
  • Smoking Cessation
  • Smoking Cessation Agents
  • Tobacco Smoking
  • Tobacco Use Cessation
  • Bupropion
  • Nicotine
  • Nicotine Replacement Therapy
  • Varenicline
  • Quinolizines
Keywords
  • Bupropion
  • Cytisine
  • Nicotine
  • Varenicline
  • Smoking
  • Benefit Assessment
  • Systematic Review
Contact
Organisation Name: Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address: IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email: berichte@iqwig.de
Copyright: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.